CLSA analysts upgraded Aurobindo Pharma (NSE:ARBN) (ARBP:IN) stock rating from Hold to Outperform, despite reducing the price target to INR1,400 from INR1,540. The revision reflects a modified ...

Aurobindo also has the highest contribution from the exports market among Indian pharma companies, and a depreciating rupee ...

The brokerage firm Macquire has maintained Outperform rating on the Aurobindo Pharma stock with target price of Rs 1,300 following the US FDA ended their inspection at Pharma Company’s biggest ...

Today’s stock recommendations feature a mix of picks from the pharmaceutical, insurance, and chemicals sectors.

What has been 52-week high of Aurobindo Pharma Ltd stocks? The highest price of Aurobindo Pharma Ltd stock is ₹1,592.00 in the last 52-week. What is the share price of Aurobindo Pharma Ltd ...

Aurobindo Pharma Limited is an India-based pharmaceutical company. The Company is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, branded pharmaceuticals ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Aurobindo Pharma Ltd.'s share price logging 14.6% fall in the last six months has driven Investec to initiate a 'fast long' on the stock, as it sees a depreciating rupee scenario to benefit, given its ...

Healthcare stocks see mixed performance as Dr Lal Pathlabs and Aurobindo Pharma rise over 2% after CLSA upgrades their ...

Aurobindo Pharma (NS:ARBN) has outperformed expectations in the fourth quarter of FY24, with both sales and EBITDA showing significant year-over-year growth. Sales increased by 17%, while EBITDA ...

Aurobindo Pharma Ltd is quoting at Rs 1197.8, up 1.65% on the day as on 12:49 IST on the NSE. The stock is up 5.66% in last one year as compared to a 9.94% jump in NIFTY and a 26.31% jump in the Nifty ...